Skip to main content
77°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atea Pharmaceuticals Inc
(NQ:
AVIR
)
3.900
+0.120 (+3.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Atea Pharmaceuticals Inc
< Previous
1
2
3
4
5
Next >
Is There Any Hope for Atea Pharmaceuticals Stock?
November 04, 2021
If its coronavirus pill project can't be salvaged, it'll be trouble for investors.
Via
The Motley Fool
Exposures
COVID-19
3 Beaten-Down Biotech Stocks -- Can They Recover?
October 31, 2021
Each for reasons of their own, Atea Pharmaceuticals, Omeros, and Novavax have had a very tough time this year.
Via
The Motley Fool
How Atea's Clinical Flop Shakes Up the COVID-19 Pill Market
October 29, 2021
Merck and Pfizer could benefit from Atea's setback.
Via
The Motley Fool
Exposures
COVID-19
Pfizer Conceding Race in Hospitalized Covid Because of Todos Medical's Triple MOA Antiviral
October 28, 2021
Photo by Christina Victoria Craft on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a...
Via
Benzinga
3 Top COVID Stocks -- Are They Tricks or Treats?
October 26, 2021
Ghosts, goblins, ghouls? No, it's three vaccine stocks.
Via
The Motley Fool
Exposures
COVID-19
Expert Ratings For Atea Pharmaceuticals
October 20, 2021
Over the past 3 months, 5 analysts have published their opinion on Atea Pharmaceuticals (NASDAQ:
Via
Benzinga
Was Atea Pharmaceutical's Flop Predictable?
October 26, 2021
Were warning signs there for investors all along?
Via
The Motley Fool
Exposures
COVID-19
How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More
October 25, 2021
Last week, the five biggest stock market losers declined between about 75% and 37%. Below is a look at each stock and what they may have in the cards going forward. Galera...
Via
Benzinga
Why Atea Pharmaceuticals Stock Got Crushed This Week
October 22, 2021
A mid-stage trial miss caused investors to hit the exits this week.
Via
The Motley Fool
Exposures
COVID-19
10 Biggest Price Target Changes For Wednesday
October 20, 2021
Mizuho cut QUALCOMM Incorporated (NASDAQ: QCOM) price target from $180 to $165. QUALCOMM shares fell 0.3% to $132.13 in pre-market trading. Deutsche Bank raised the price...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021
October 20, 2021
Upgrades For Iridium Communications Inc (NASDAQ:IRD...
Via
Benzinga
Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher
October 19, 2021
Toward the end of trading Tuesday, the Dow traded up 0.33% to 35,374.03 while the NASDAQ rose 0.54% to 15,103.67. The S&P also rose, gaining 0.55% to 4,511.35. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
52 Biggest Movers From Yesterday
October 20, 2021
Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares climbed 42.6% to close at $9.51 on Tuesday. Xiaobai Maimai said Xiaobao An resigned as CEO. Kaival Brands Innovations Group...
Via
Benzinga
Why Ulta and Atea Rained on the Nasdaq's Parade Tuesday
October 19, 2021
Even with downward pressure from these two stocks, the Nasdaq Composite moved higher again.
Via
The Motley Fool
Topics
Stocks
Exposures
COVID-19
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 19, 2021
Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 18.27% to $5.76 during Tuesday's regular session. Redhill Biopharma's stock is trading at a volume of 2....
Via
Benzinga
Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge
October 19, 2021
Midway through trading Tuesday, the Dow traded up 0.47% to 35,423.05 while the NASDAQ rose 0.59% to 15,110.79. The S&P also rose, gaining 0.61% to 4,513.69. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Atea Pharmaceuticals Is Imploding Today
October 19, 2021
The company's oral COVID-19 treatment looks like a dud in the mild-to-moderate COVID-19 setting.
Via
The Motley Fool
Exposures
COVID-19
AVIR Stock: The Oral Covid-19 Therapy News That Has Atea Pharmaceuticals Plunging Today
October 19, 2021
Atea Pharmaceuticals (AVIR) stock is on the move Tuesday after providing an update from its Phase 2 Moonsong clinical trial update.
Via
InvestorPlace
Exposures
COVID-19
Atea Pharma Stock Crashes After Merck-Rivaling Covid Pill Lags In Midstage Test
October 19, 2021
Atea Pharmaceuticals said its Covid pill didn't lower viral loads in all patients.
Via
Investor's Business Daily
Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance
October 19, 2021
Following the market opening Tuesday, the Dow traded up 0.29% to 35,361.89 while the NASDAQ rose 0.31% to 15,068.75. The S&P also rose, gaining 0.39% to 4,503.81. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 19, 2021
Gainers Entasis Therapeutics Hldg (NASDAQ:ETTX) shares moved upwards by 16.72% to $3.63 during Tuesday's pre-market session. The company's market cap stands at $...
Via
Benzinga
Why Are Atea Pharmaceuticals Shares Plunging Today?
October 19, 2021
Atea Pharmaceuticals Inc (NASDAQ: AVIR) has reported data from the Phase 2 MOONSONG trial of AT-527 in the outpatient setting in patients with mild or moderate...
Via
Benzinga
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
October 18, 2021
Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral...
Via
Talk Markets
The Next Challenge For Covid Stocks Is Also A Cash Cow For These Companies
October 15, 2021
Companies working on sorely needed Covid treatments are innovating to keep up.
Via
Investor's Business Daily
3 COVID Stocks That Can Turn $1,000 Into $10,000
October 12, 2021
Our trio of contributors offer three COVID-19 stocks that will zoom higher, even as we emerge from the pandemic.
Via
The Motley Fool
Exposures
COVID-19
Molnupiravir? Not So Fast. What About Tollovir? — Here's Why You Should Know What That Means
October 12, 2021
Photo by Martin Sanchez on Unsplash Merck (NYSE: MRK) announced last Friday impressive results from its COVID-19 antiviral, molnupiravir. As vaccines are requiring a third booster...
Via
Benzinga
Exposures
COVID-19
10 Health Care Stocks With Unusual Options Alerts In Today's Session
October 08, 2021
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option...
Via
Benzinga
Which COVID-19 Pill Stock Is the Best Buy?
October 05, 2021
Merck, Pfizer, and Atea are set to do battle next year in the COVID-19 pill market.
Via
The Motley Fool
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
Upgrades Wolfe Research upgraded the previous rating for PACCAR Inc (NASDAQ:
Via
Benzinga
3 Stocks That Might Soar With Pills for COVID
October 03, 2021
Are we seeing a major shift into oral medications for COVID? Our Foolish roundtable picks three of the strongest stocks in this rising subsector.
Via
The Motley Fool
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.